HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inhibition of programmed cell death by cyclosporin A; preferential blocking of cell death induced by signals via TCR/CD3 complex and its mode of action.

Abstract
Cyclosporin A (CsA) is reported to inhibit programmed cell death. We confirmed this by using T-cell hybridomas which are inducible to programmed cell death by activation with immobilized anti-CD3 antibody or with anti-Thy 1.2 antibody. Cell death and DNA fragmentation, characteristic features of programmed cell death, were almost completely blocked by CsA or FK506. To investigate whether CsA inhibits only the cell death through the signals via the TCR/CD3 complex or all of the programmed cell death induced by various reagents, we further established CD4+8+ thymic lymphomas which result in programmed cell death after activation with calcium ionophore, dexamethasone, cyclic AMP or anti-CD3 antibody. It was revealed that CsA could block only the cell death mediated by the TCR/CD3 complex. For the clarification of the site of action of CsA, Ca2+ influx and endocytosis of receptors after stimulation with anti-CD3 antibody were monitored in the presence of CsA, and no significant effects of CsA were observed. Furthermore, prevention of cell death was examined by adding CsA at various periods of time after initiation of culture. CsA was found to exert its effect even when added after 4 h of cultivation, and the kinetic pattern of suppression was similar to that of the suppressive effect on IL-2 production. These observations indicate that in the events of programmed cell death, the major site of action of CsA will not be the inhibition of the immediate membrane events after activation of the TCR/CD3 complex but rather the interference in the function of molecules that transmit signals between membrane events and the activation of genes in the nucleus.
AuthorsD Yasutomi, C Odaka, S Saito, H Niizeki, H Kizaki, T Tadakuma
JournalImmunology (Immunology) Vol. 77 Issue 1 Pg. 68-74 (Sep 1992) ISSN: 0019-2805 [Print] England
PMID1383138 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • CD3 Complex
  • Interleukin-2
  • Isoantibodies
  • anti-Thy antibody
  • Cyclosporine
  • DNA
  • Calcium
  • Tacrolimus
Topics
  • Animals
  • CD3 Complex (drug effects, immunology)
  • Calcium (metabolism)
  • Cell Survival (drug effects)
  • Cells, Cultured
  • Cyclosporine (pharmacology)
  • DNA (drug effects)
  • Dose-Response Relationship, Drug
  • Endocytosis (drug effects)
  • In Vitro Techniques
  • Interleukin-2 (biosynthesis)
  • Isoantibodies (immunology)
  • Mice
  • T-Lymphocytes (drug effects)
  • Tacrolimus (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: